UiPath’s PATH edge in today’s automation race comes down to one thing: how effectively its platform converts AI innovation into repeatable enterprise efficiency. The company is moving beyond scripted ...
Kiniksa Pharmaceuticals leverages ARCALYST as it is a first-in-class FDA-approved treatment for recurrent pericarditis, driving recurring revenue and strong growth. Q3 FY2025 ARCALYST revenue was $180 ...
Stride, Inc. LRN continues to deliver robust margin growth. In third-quarter fiscal 2025, the company reported a robust performance with adjusted EBITDA rising 40% year over year to a record $168.3 ...
Hosted on MSN
U.S. Bancorp targets positive operating leverage of 200+ basis points in Q4 2025 as fee revenue momentum accelerates
Stern provided forward-looking guidance: "In the fourth quarter, we expected net interest income on a fully taxable equivalent basis to be relatively stable to our third quarter level of $4.25 billion ...
TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY), an internationally regulated sports betting and media company, today announced financial results for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results